Not all Politics is Local: Extracellular Vesicles in Acute Rejection

Acute cellular rejection (ACR) remains a major cause of early graft injury and an important risk factor for chronic lung allograft dysfunction after lung transplantation.1 Although adaptive alloimmune responses play a central role in rejection pathogenesis, increasing evidence indicates that innate immune activation, tissue injury responses, and metabolic regulation within the graft microenvironment also critically shape the trajectory of allograft inflammation. Identifying mechanisms that integrate cellular stress responses with immune signaling may therefore provide new opportunities to refine therapeutic strategies aimed at preserving graft function. In this issue of Transplantation, Rahman et al2 extend their prior work on the metabolic kinase liver kinase B1 (LKB1) by examining its presence in circulating small extracellular vesicles (sEVs) in lung transplant recipients with ACR. The authors report that LKB1 levels are reduced in plasma-derived sEVs from patients undergoing ACR and partially recover after antirejection therapy. Complementary in vitro experiments demonstrate that sEVs containing wild-type LKB1 activate AMP-activated protein kinase (AMPK) signaling in bronchial epithelial cells and attenuate lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor alpha. Together, these findings suggest that alterations in sEV-associated metabolic signaling pathways may contribute to the inflammatory environment observed during ACR. EVs have emerged as important mediators of intercellular communication, capable of transferring proteins, lipids, and nucleic acids between injured tissue and immune cells.3 In transplantation, circulating vesicles have been proposed to reflect ongoing graft injury and may participate in shaping immune activation.4 By linking vesicle-associated LKB1 to downstream AMPK signaling, the present study highlights a potential interface between immunometabolism and EV biology. LKB1 is a central regulator of cellular energy homeostasis and has been implicated in controlling inflammatory signaling pathways, including nuclear factor kappa B activity and cytokine production.5 The possibility that metabolic regulators can be transferred between cells via vesicles suggests an additional layer of regulation through which injured graft tissue may influence immune responses. The proposed LKB1-AMPK axis is particularly intriguing in the context of lung transplantation, where ischemia/reperfusion injury, alloimmune activation, and environmental exposures collectively impose substantial metabolic stress on epithelial and endothelial cells. Under these conditions, metabolic checkpoints may function to calibrate inflammatory responses and maintain tissue integrity. Vesicle-mediated signaling may therefore represent a mechanism through which stressed parenchymal cells modulate the activation state of neighboring cells, potentially influencing the balance between injury and repair. At the same time, the interpretation of EV signaling pathways remains technically challenging. sEVs isolated from plasma represent a heterogeneous population derived from multiple cellular sources, including epithelial, endothelial, hematopoietic, and platelet compartments.6,7 Although the authors use multiple complementary approaches, including nanoparticle tracking analysis, ExoView profiling of tetraspanin markers, and immunoblot detection of canonical vesicle-associated proteins, further studies may help refine the cellular origin and functional specificity of vesicle subpopulations most relevant to rejection biology. Improved resolution of vesicle heterogeneity may enhance our understanding of how graft-derived versus recipient-derived vesicles contribute to immune modulation. The relationship between metabolic signaling pathways and inflammatory mediators, such as nitric oxide, is also complex and context dependent.8 Nitric oxide has been implicated in both tissue injury and immune regulation across a range of transplantation models, with effects influenced by timing, cellular source, and microenvironmental conditions.9 The present findings linking LKB1 signaling to reduced inducible nitric oxide synthase expression raise the possibility that metabolic pathways may influence the balance between proinflammatory and regulatory responses during ACR. Whether LKB1 primarily functions as a direct regulator of rejection severity or reflects broader metabolic adaptation to tissue stress will require further investigation using complementary experimental models. Despite these considerations, the study by Rahman et al2 contributes to a growing body of literature emphasizing the importance of metabolic regulation in shaping immune responses after transplantation. Integration of EV biology with immunometabolic signaling represents a promising direction for future investigation.10 Elucidating how metabolic checkpoints influence communication between parenchymal and immune cells may ultimately provide new insights into mechanisms governing graft injury and recovery. In summary, this work proposes a link between reduced LKB1 content in circulating EVs and altered inflammatory signaling during acute rejection. By highlighting the potential role of vesicle-mediated metabolic communication, the study underscores the evolving view that alloimmune responses are influenced not only by antigen recognition but also by dynamic cellular stress responses within the graft microenvironment. Continued investigation of these pathways may help identify new strategies to promote graft stability and long-term transplant survival. ACKNOWLEDGMENTS The authors thank members of the Krupnick Laboratory for insightful discussions during the preparation of this article.